NRAS, NRAS, Which Mutation Is Fairest of Them All?

Christine Grill1, Lionel Larue1

  • 1Institut Curie, Paris Sciences et Lettres Research University, Institut National de la Santé et de la Recherche Médicale U1021, Normal and Pathological Development of Melanocytes, Orsay, France; Université Paris-Sud, Université Paris-Saclay, Centre National de la Recherche Scientifique Unité Mixte de Recherche 3347, Orsay, France; Equipe Labellisée Ligue Contre le Cancer, Orsay, France.

Insights

Mutations in NRAS, common in melanoma, activate distinct signaling pathways. NRAS G12 impacts the phosphoinositide 3-kinase (PI3K) pathway, while NRAS Q61 affects the mitogen-activated protein kinase (MAPK) pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • NRAS mutations occur in 28% of melanomas, primarily at G12 or Q61 hotspots.
  • Understanding NRAS mutation-specific signaling is crucial for targeted melanoma therapies.

Purpose of the Study:

  • To investigate the distinct downstream signaling effects of NRAS G12 and Q61 mutations in melanoma.

Main Methods:

  • Phosphoproteomic analysis was performed on primary human melanocytes engineered with NRAS G12 and Q61 mutations.
  • Comparative analysis of signaling pathway modulation and kinase overexpression.

Main Results:

  • NRAS G12 mutation distinctly modulated the phosphoinositide 3-kinase (PI3K) pathway, leading to PIM2 kinase overexpression.
  • NRAS Q61 mutation was associated with the mitogen-activated protein kinase (MAPK) pathway and CK2α overexpression.

Conclusions:

  • NRAS G12 and Q61 mutations activate divergent signaling cascades in melanoma.
  • These findings highlight pathway-specific therapeutic strategies for NRAS-mutated melanomas.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
The Ras Gene02:38

The Ras Gene

2.4K
Mutations01:39

Mutations

Overview
95.6K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.2K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K